$Amazing $Biotech & $olid $Microcap $tocks

[value1008]

DTEA - Ash, the biggest problem with this co. is the quality of the management team, judging from shareholder comments going back a few years over at S.Alpha articles.

Young founder David Segal left in 2016 and his cousin Herschel (a big loser on his publicly-traded Canadian garment biz) has done nothing but run the DTEA stockprice into the ground the past two years.

Big investor money has fled, especially in the past 6 weeks with TDM, then EdgePoint, then finally Highland all selling out (well, TDM still has a measly 10% of their shares). Those were DTEA's three biggest institutional investors. Doesn't inspire much confidence....

There are big doubts about whether DTEA could sell any CBD products at its provincial stores because of NOT HAVING A LICENSE.

They've brought on a board member with experience in the CBD biz but has DTEA even begun filing for a license to sell CBD products at any of its stores? Apparently not, according to this S.Alpha author Cornerstone from Oct. 3, 2018:

https://seekingalpha.com/article/4209712-davids-tea-latest-victim-current-cannabis-frenzy

[...] any form of participation between DAVIDs TEA and cannabis firms would be subject to the rules and regulations regarding the sale and distribution of cannabis. Shoppers Drug Mart (OTCPK:LBLCF) was awarded its license and it plans to start selling cannabis through its pharmacies once legalization begins on October 17th. However, DAVIDs TEA has not applied for any cannabis license as far as we know and its business plan does not involve cannabis retailing at this point, which means that potential partners would not be able to sell cannabis through DAVIDs TEA because the latter does not have a license. Getting a license could take months to a year and there is no guarantee that DAVIDs TEA would be successful in obtaining one. Thus, we think the path to a partnership is still nothing but uncertain.

Final Words
DAVIDs TEA has a core business in selling tea that has been struggling for years. When you add cannabis into the mix, investors start to fancy all sorts of possibilities and before you know share price is up 63% in one day. However, this is a company that has failed to turn around its core operations since its IPO and its same-store traffic continues to decline at an alarming rate. If you are investing in DAVIDs TEA with the hope that its fate could be transformed by the cannabis sector, you need to recognize that the underlying stock is not worth nearly where it closed on Tuesday. The stock has been a disappointment after losing 87% of its value since IPO just three years ago. Will cannabis save DAVIDs TEA? We don't think so, and certainly, you should not bet your hard-earned money on this stock.